Learn About Recursion Pharmaceuticals's AI Products
Create a free account to access in-depth lessons on each tool and model.
Start Learning Free📋About Recursion Pharmaceuticals
Updated June 15, 2026Recursion Pharmaceuticals (NASDAQ: RXRX) is an AI-driven drug discovery company using biology-scale datasets and machine learning to compress drug development from 12 years to 4-5. After merging with Exscientia in November 2024, Recursion offers end-to-end AI drug discovery from target identification through candidate optimization, with 5 clinical programs and partnerships with Sanofi, Roche, Bayer, and Merck.
🛠️Products & Tools (1)
AI-driven drug discovery company using biology-scale datasets and machine learning to identify novel treatments, compressing the drug development timeline from 12 years to 4-5.